USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cardinal Health Switzerland 515 GMBH

USPTO PatentsView assignee record - 44 granted patents across 11 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cardinal ranks #7,384 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 11 technology areas.

#7,384
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.7/100)
13.6
avg claims per patent
-43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7384 · Foreign Corporation #7,384 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 44 grants
  • UPPER-Q #7,384/49,997
  • PHOTO-FINISH Belenos Clean Power…
  • CPC-FOCUS A61F · 11 areas
  • INNOV-THIN 35.7/100
  • CLAIMS-RICH 13.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -43% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Belenos Clean Power Holding AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cardinal’s 35.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cardinal

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cardinal's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cardinal?

Each dot is one of Cardinal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cardinal’s own 13.6 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cardinal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 43.944.044.04444.044.044.1 510152025 Granted patents (volume) Avg claims / patent Belenos Clean Power Holding AG - 44, 15.59Belenos Clean Pow…BlueHalo, LLC - 44, 16.07BluehaloBombardier Primove GmbH - 44, 16.16Bombardier PrimoveBourns, Inc. - 44, 20.3BournsCatholic University Industry Academic Cooperation Foundation - 44, 6.7Catholic Universi…Consolidated Edison Company OF NEW York, Inc. - 44, 16.14Consolidated Edis…Coretech System Co., Ltd. - 44, 11.89Coretech SystemCattron North America, Inc. - 44, 21Cattron North Ame…Cardinal Health Switzerland 515 GMBH - 44, 13.55Cardinal Health S…
Cardinal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cardinal's grants concentrate

Cardinal Health Switzerland 515 GMBH is a focused PatentsView assignee: 11 CPC subclasses with 52.3% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (12 grants) versus a trough of 3 in 2021. By volume, Cardinal sits between Belenos Clean Power Holding AG and Cattron North America, Inc..

Cardinal's three-year grant acceleration

Cardinal Health Switzerland 515 GMBH shows 6 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cardinal's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cardinal holds 44 patents at rank #7,384, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cardinal

By rank, the assignees closest to #7,384 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Cardinal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cardinal, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Cardinal ranks #288 of 3,082 assignees by patent count in that subclass.

Cardinal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2468101214 2016201720182019202020212022 6
USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Cardinal Health Switzerland 515 GMBH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 12 27.3%
2017 5 11.4%
2018 6 13.6%
2019 5 11.4%
2020 7 15.9%
2021 3 6.8%
2022 6 13.6%

Which technologies does Cardinal Health Switzerland 515 GMBH patent most?

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cardinal Health Switzerland 515 GMBH's patent record in context - here's where to go next.

  • Cardinal Health Switzerland 515 GMBH's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 52.3% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #7,384 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cardinal Health Switzerland 515 GMBH against Belenos Clean Power Holding AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.